Above are the two classical types of lung cancers: Non-small cell lung cancers (NSCLC, left) and small-cell lung lung cancer (SCLC, right). NSCLC is a less aggressive and more common form of lung cancer (about 80-85% of cases). SCLC, however, is very aggressive and metastasizes (spreads) to other parts of the body, including the lymph nodes.
If caught in time, NSCLC has the best outcomes and there exist different therapeutic options, including surgery, often leading to a complete cure. Unfortunately, SCLC are the most aggressive and incurable, with therapies only providing temporary remission at best.
However, in the lab we have been able to manipulate metabolic pathways to stop growth and proliferation of SCLC in 24-48 hours, with cells dying off. If we can do it in the lab, we MUST try it in vivo with animal models (mice). This is why we need your help. 11 million people per year still lose the battle to cancer and the amount keeps growing. Please support our work. 🙏
#cancermetabolism #cancerfoundation @inigosanmillan ...